mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.005 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.005 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.006 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.008 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.008 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.008 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.009 |